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DAVID

EDITORIAL
B. NASH, MD, MBA

Few would dispute the premise that prevention, early detection, and early intervention form the first line of defense on the disease management (DM) continuum. That being the case, our national statistics on preventive health should be raising concerns
throughout the industry. The US healthcare delivery system continues to fall woefully
short of its prevention targets. On the international scene, the United States lags behind
countries with less wealth and less technological savvy. Commentaries abound on the
problems, but recently I became aware of an organization with an exciting goal and a
novel solution for bringing preventive medicine into the mainstream.
U.S. Preventive Medicine, Inc. (USPM) was founded by Christopher Fey, a former president and CEO of HealthCare USA, a multistate health maintenance organization, and
senior officer of Coventry Health Care Corporation. A number of years ago, Mr. Fey had
a life-altering experience. He witnessed his brother-in-law, a 39-year-old man in seemingly excellent physical condition, suffer a massive stroke that resulted in permanent
right-sided paralysis, and speech and memory impairment. Following the event, physicians concluded that his brother-in-law’s risk factors could have been identified and his
disease state detected by means of available technological screening devices. His was a
condition for which effective drug therapy and other interventions were available. This
event and its consequences were preventable.
Having experienced firsthand the devastating consequences of a “broken” system that
fails to respond until a condition produces symptoms, Mr. Fey became an “evangelist”
for prevention and early detection. In founding USPM, he translated an interesting concept into an innovative model for preventive health in a consumer-driven market.
In the following pages we provide a brief history of and current status report on the
state of preventive health in the United States, and we present an overview of this company’s solution as one example of the untapped potential for innovation in the delivery
of preventive services. I hope that the information contained herein will inspire you and
your colleagues to join the conversation about the direction the United States will take
with regard to improving access to screening and preventive services and enriching the
lives of all citizens. As always, I welcome your comments. I can be reached at
David.Nash@jefferson.edu.
PREVENTIVE HEALTH IN THE UNITED STATES
A look back

Over the past few decades, the politics
of prevention have undergone an evolution. In the late 1960s and early 1970s, prevention was at the forefront of healthcare
reform. With very little controversy, vaccination, promotion of lifestyle changes,
S-2

mass screenings, and safety regulations
became widely accepted as strategies for
improving health and reducing expenditures. By the mid-1980s, some unanticipated outcomes of these strategies had become apparent. Serious and permanent
injuries were attributed to the vaccines
used for immunizations. Lifestyle factors
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were being used as the basis for raising
health insurance rates and/or denying
consumer eligibility for disability benefits. Preventive screenings had become
suspect as potential tools for a range of
activities, from denying employment to
selective abortion. Lawsuits were brought
charging that occupational safety standards were being used to exclude people
from certain jobs.1
In the late 1980s, the US Preventive Services Task Force (USPSTF) launched the
first edition of its Guide to Clinical Preventive Services under the auspices of the
Agency for Healthcare Research and Quality (AHRQ).2 The guide contained recommendations that helped to establish the
importance of including prevention in primary health care, ensuring health plan
coverage for effective preventive services,
and holding healthcare providers and systems accountable for delivering preventive
care. The guide has been updated periodically, and the guidelines contained therein
continue to form the basis of clinical standards for professional societies, healthcare
organizations, and medical quality review
groups. Current USPSTF recommendations for preventive services are listed in
Table 1.
With the growth of managed care organizations in the 1980s and 1990s, insurance
coverage for preventive services was introduced, and a new emphasis was placed on
disease prevention and health education.
Primary care providers were encouraged,
and often “rewarded,” for focusing on
screening and prevention. In the early
1990s, disease state management programs
began to appear, providing aggressive prevention of disease progression and complications as well as treatment for chronic
conditions.
Today the United States is the world’s
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richest, most technologically advanced nation, but US preventive health statistics
continue to fall dramatically short of expectations. The associated costs are alarmingly high. Consider the following:
• More than 20 million Americans (7%
of the population) have diabetes,
though experts estimate that nearly
30% of this population remains undiagnosed.3
• According to the National Kidney Foundation, more than 20 million Americans
have undetected moderate chronic kidney disease and another 20 million are at
risk.4
• According to the American Heart Association, the lifetime risk of developing
hypertension is approximately 90% for
adults between the ages of 55 and 65; one
third of those affected are not aware they
have this condition.5
• Chronic obstructive pulmonary disease
(COPD) also warrants attention because
large numbers of cases are undiagnosed.
In 2001, at a time when more than 12 million adults were diagnosed with COPD,
experts estimate that an additional 16
million remained undiagnosed and
therefore untreated. Failure to treat can
be fatal—COPD is the fourth leading
cause of death in the United States—and
it’s costly; in 2000, national COPD costs
totaled more than $32 billion, split nearly
evenly between direct and indirect
costs.6
• At least half of the deaths from cancers
(564,830 projected in 2006) could be prevented by greater use of established
screening tests and the application of existing knowledge.7
In their recent study, “Disease and Disadvantage in the United States and in En-
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TABLE 1
U.S. PREVENTIVE SERVICES TASK FORCE (USPSTF) RECOMMENDED PREVENTIVE SERVICES (2005)
Adults

Recommendations
Alcohol misuse screening and behavioral counseling interventions
Aspirin for the primary prevention of cardiovascular eventsa
Bacteriuria, screening for asymptomatic
Breast cancer, chemopreventionb
Breast cancer, screeningc
Breastfeeding, behavioral interventions to promoted
Cervical cancer, screeninge
Chlamydial infection, screeningf,g
Colorectal cancer, screeningh
Dental caries in preschool children, preventioni
Depression, screeningj
Diabetes mellitus in adults, screening for type 2k
Diet, behavioral counseling in primary care to promote a
healthyl
Hepatitis B virus infection, screeningm
High blood pressure screening
Lipid disorders, screeningn,o
Obesity in adults, screeningp
Osteoporosis in postmenopausal women, screeningq
Rh (D) incompatibility, screeningr,s
Syphilis infection, screeningt
Tobacco use and tobacco-caused disease, counseling to preventu,v
Visual impairment in children younger than age 5 years,
screeningw
aAdults

Special populations

Men Women
X
X

X
X

X

X
X
X
X
X
X

X
X
X

X
X
X

X
X
X

X
X
X
X

X
X

X
X

Pregnant
women Children
X
X

X
X
X

X

X
X
X
X

at increased risk for coronary heart disease.
with women at high risk for breast cancer and at low risk for adverse effects of chemoprevention.
cMammography every 1–2 years for women 40 and older.
dStructured education and behavioral counseling programs.
eWomen who have been sexually active and have a cervix.
fSexually active women 25 and younger and other asymptomatic women at increased risk for infection.
gAsymptomatic pregnant women 25 and younger and others at increased risk.
hMen and women 50 and older.
iPrescribe oral fluoride supplementation at currently recommended doses to preschool children older than 6
months whose primary water source is deficient in fluoride.
jIn clinical practices with systems to assure accurate diagnoses, effective treatment, and follow-up.
kAdults with hypertension or hyperlipidemia.
lAdults with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease.
mPregnant women at first prenatal visit.
nMen 35 and older, and women 45 and older.
oYounger adults with other risk factors for coronary disease; screening for lipid disorders to include measurement of total cholesterol and high-density lipoprotein cholesterol.
pIntensive counseling and behavioral interventions to promote sustained weight loss for obese adults.
qWomen 65 and older, and women 60 and older at increased risk for osteoporotic fractures.
rBlood typing and antibody testing at first pregnancy-related visit.
sRepeated antibody testing for unsensitized Rh (D)–negative women at 24–28 weeks gestation unless biological
father is known to be Rh (D) negative.
tPersons at increased risk and all pregnant women.
uTobacco cessation interventions for those who use tobacco.
vAugmented pregnancy-tailored counseling to pregnant women who smoke.
wTo detect amblyopia, strabismus, and defects in visual acuity.
From Guide to Clinical Preventive Services (2005). Available at: www.ahrq.gov/clinic/pocketgd/gcps1.htm.
bDiscuss
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gland,” Banks and colleagues concluded
that the US population in late middle age
is less healthy than the equivalent British
population, with respect to self-reported
chronic conditions and biological markers
of disease, despite considerably greater per
capita spending on health care (US $5274
vs. UK $2164 [adjusted].)8 The differences
reportedly exist at all levels of socioeconomic status.
As a nation, our failure to detect conditions and initiate early intervention has resulted in a precipitous rise in the prevalence and severity of chronic diseases.9
Chronic conditions account for 70% of all
deaths in the United States, and the costs
associated with chronic conditions account
for more than 60% of the nation’s medical
care costs. Perhaps most unsettling is that,
for a majority of chronic diseases, onset can
be delayed or progression limited by avoiding risky behaviors, increasing physical activity, and obtaining life-saving screening
services.
Why is preventive health care so far
from where it should be in the world’s
wealthiest nation? There are a variety of
possible explanations. Some commercial
insurance carriers ration coverage by adhering to conservative standards and recommendations. In the public sector, some
restrictions on coverage for preventive
services are even more stringent. For instance, Medicare does not cover preventive services for senior citizens, and most
Medicaid carriers restrict preventive care
to minimal standards and recommendations. But the problem is more pervasive.
A recent survey of 153,000 adults concluded that only 3% of US citizens adhere
to the four key healthy lifestyle characteristics (ie, not smoking, maintaining
healthy weight, eating adequate amounts
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of fruits and vegetables, and exercising
regularly).10 Almost 10% of respondents
admitted that they did not adhere to any
of the four characteristics.
Consumer-driven healthcare and its effect on
preventive health
Several market forces are beginning to
align, creating ideal conditions for a major
transition in healthcare delivery:
1. The projected impact of the aging “babyboom” population
2. The ever-escalating cost of providing
health care
3. The increasing role of consumers in
managing all aspects of their health
Today more than 80 million “babyboomers” are beginning to attain senior status with a previously unheard-of passion
for enjoying healthy, active lives. The impact of this generation on established markets, business, and society promises to be
challenging. On the positive side, medical
and information technology are advancing
at a rapid pace, enabling ever higher degrees of personalized care for a population
demanding proactive care to ensure
longevity and quality of life. On the flip
side, the cost of care continues to outpace
the economy’s ability to pay for “traditional” care. In the final analysis, this population may leverage their considerable
wealth and political influence to make the
necessary changes in the system.
In “Wealth Patterns among Elderly
Americans: Implications for Healthcare Affordability,” Knickman and colleagues
point out that, at nearly 17% of the gross
domestic product, health care is the largest
single industry in the United States.11 If this
trend continues, an aging population could
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overwhelm the economy’s ability to support
health care. The authors reason that a traditional approach (ie, “sick care”) delivers care
when treatment options are most costly and
outcomes are most limited. They observe
that business and consumer markets are beginning to challenge the assumption that
medical treatment should be reserved for the
“sick.” Some examples cited are:
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means of monitoring their patients’ health
and changes in conditions.
The trend toward consumer-driven
health care is beginning to reset expectations regarding who pays for prevention.
Although some employers continue to provide coverage that includes preventive services, in most cases consumers are the purchasers of preventive care. The challenge
for consumers is identifying how and
• Employers are beginning to understand where to purchase prevention.
the value of “buying health” in reducing
absenteeism and “presenteeism.” They Can prevention fit into the traditional
are becoming interested in investing in a care model?
healthy, productive workforce.
One solution is for consumers to go to a
• Consumers want to extend their physically and mentally active years, main- preventive care center for reliable, accurate,
taining or improving their quality of life and comprehensive individualized testing,
and then go to a physician for interpretation
as they age.
• Government must act to lower the long- of those test results and development of a
medical management plan. The critical facterm cost of care.
tors for the success of such a solution are a
Proactive preventive care is increasingly uniform, consistent, and accessible experiviewed as both a logical and a necessary al- ence for the consumer and for the physician.
ternative. Early diagnostic tests, assessMarket forces are already driving these
ments, and aggressive intervention in ad- changes. A combination of factors (ie, the
vance of symptoms provide an appealing financial transfer to consumers and the
alternative, given the lower cost of these trend toward proactive care) are shifting
types of interventions and the high poten- the focus and responsibility for individual
tial for positive outcomes at the presymp- health to the consumer. The new healthcare
tomatic stage.
consumer is assuming a larger role in his
As consumers assume greater financial or her personal health. For example, Heath
responsibility for the cost of their personal Savings Accounts (HSAs), in which health
health care, they are likely to demand spending is at the discretion of the indigreater influence over how their health dol- vidual, are on the rise.
lars are spent. Consumers may demand opIn recent years, there has been an untional tests and procedures in order to es- precedented rise in consumer involvetablish, in concert with their physicians, an ment in healthcare purchasing and deciaccurate baseline for their health. Such a sion making. The information necessary
baseline can be useful when making pur- for making informed healthcare decisions
chase decisions on the type and level of is becoming readily available via the Inhealth coverage needed. Baseline and on- ternet, personal health record (PHR) techgoing trend information will offer con- nology, public service materials, and from
sumers’ clinical teams a more effective healthcare insurers and employers.

ONE COMPANY’S INNOVATIVE SOLUTION:
THE U.S. PREVENTIVE MEDICINE, INC. MODEL

Although navigating the healthcare
system in today’s environment is often
challenging and frustrating, consumers
have had no alternative but to “take
charge” in the not-so-user-friendly world
of health care. U.S. Preventive Medicine,
Inc. (USPM) sees its role as offering
consumers the services of a “captain” to
help them plot their course for healthier,
active lives—with an emphasis on prevention.
USPM was founded on the premise that
healthcare service delivery is entering a period of transition in the United States. Traditionally, the focus of care has been reactive, with services delivered only when a
patient’s illness becomes symptomatic. As
the system evolves, the focus has been
shifting increasingly to proactive, preventive care in which consumers are treated on
a presymptomatic basis—a concept that
dovetails with the philosophy of disease
management.
Culture of prevention
The US healthcare system is grounded in
a medical infrastructure wherein care is
provided and reimbursed based on a perceived doctor-patient relationship in which
“prevention” is defined simply: “eat right,
exercise, take vitamins, and see the doctor
regularly.” USPM’s goal is to reorganize
the prevention arena by driving a transition from “legacy of treatment” to a “culture of prevention.” Moving to a culture of
prevention entails expanding the definition
to include understanding what is going on
inside the body (eg, genetics, blood
chemistries).

Building a prevention ecosystem
The USPM model takes a comprehensive
approach to prevention, employing multiple components and a multipart mission to
create a “prevention ecosystem.” The broad
goals include:
• Creating a national system of consumer- and employer-focused preventive care centers established in conjunction with hospitals and physician
groups. The centers for preventive medicine (CPM) will provide consumers and
employers with point-of-care preventive
services for health diagnostics, assessment, counseling, and medical intervention as appropriate.
• Educating, informing, and motivating
consumers and employers to pursue
prevention lifestyles and to utilize virtual and physical preventive services.
In a television program format with a focus on “entertainment,” the company
seeks to influence consumer health behaviors in areas such as fitness, healthy
aging, and wellness. Theoretically, the
convenience of receiving this information and education in the home environment will increase the likelihood of consumer involvement.
• Functioning as a holding company for
units in the “prevention ecosystem.”
Units will include a licensing group for
CPMs; The Prevention Channel; online
prevention services (ie, Preventionchannel.com); group prevention services (ie,
disease management services); and research (eg, data mining, clinical research). USPM Holding Company revenue would flow from licensing fees,
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profit and revenue sharing, advertising,
products and services, “permissionbased” data mining, clinical research,
disease management, and value appreciation.
USPM sees its role as a catalyst in
pulling divergent interests (ie, employers,
consumers, government) together in a
business model focused on creating a culture of prevention. Mr. Fey admits, “It
will not be a quick or cheap fix, but it
needs to happen. We need a model in
which every player wins.” An important
element in making this transition is recognizing the differences between individual consumer health and population
health; a model for individual health must
go beyond a population model approach
(eg, educating the population to exercise
and take vitamins). An individual health
model must incorporate technologies that
screen for and monitor chronic conditions. “Cardiovascular disease takes 30
years to kill a person. A person with this
condition needs to know about it as early
as possible and seek appropriate treatment to achieve the best outcome.”
Promoting the cause of individualized
prevention is the first step. The real
dilemma lies in moving the healthcare delivery system toward providing all necessary preventive services. A recent article on
women’s health reported an alarmingly
high rate of missed diagnoses of heart disease in women, but there is no public outcry. Preventive health rarely hits the radar
screen. “People don’t walk around asking
for the nearest—or best—preventive health
center.”
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named “The Prevention Channel.” The Prevention Channel is designed to deliver prevention messages in an entertaining way,
on the order of the History Channel or the
Discovery Channel. Programs or “soap operas” will focus on common health elements that a viewer can change by taking
some action. For example, diabetes may be
woven into a story in such a way that viewers begin to understand this health issue on
a deeper, personal level. By identifying
with the characters, viewers may become
better equipped to recognize possible early
symptoms of common chronic illness in
themselves and in their family members.
Prevention topics will include heart disease, stroke, cancer screening, and aging
gracefully. The message—“70 is the new
middle age.”

PreventionChannel.com. The Prevention
Channel programs may motivate consumers to take some action regarding
their personal health. Viewers with concerns about their health will be directed
to virtual prevention services online (ie,
PreventionChannel.com) where they may
complete user-friendly, comprehensive
assessments that predict risk levels for
various conditions. Consumers, in collaboration with their healthcare providers,
can use this knowledge to determine appropriate interventions and measure results.
Online and paper programs have been
designed to improve participant health and
postpone morbidity by reducing health
risks, promoting self-efficacy, and instilling
self-care skills. There are basic programs
and programs designed for the needs of
special populations. These interventions
The Prevention Channel. USPM’s model are grounded in the science of behavioral
envisions a communication component change and draw upon the expertise of
with a novel intervention—a cable channel practicing clinicians and health educators.
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A medical director oversees panels of clinicians who continually review medical and
scientific literature for the most current information and incorporate it into the organization’s processes.
USPM CPMs
The core of the USPM system is a national
network of CPMs. With support from a national advisory board, a medical advisory
board, and relationships with national
medical organizations (eg, ACPM), these
centers are designed to bridge the gap between traditional, reactive medicine and
modern, proactive medicine. CPMs have
the potential for positive impact on the
quantity and quality of preventive health
in the communities they serve by “defining
the preventive experience, providing a
physical presence, and creating credibility,
content, and authority.”
In the traditional, illness-focused model,
the healthcare or hospital system is designed to intervene at late, acute, or symptomatic stages when outcomes are poor
and costs are high. The CPM model focuses on preventing disease from the outset by identifying it at the earliest point
when outcomes are best and costs are
lowest. USPM partners with hospitals
and physician groups in co-ownership
arrangements of its branded CPMs. Conceptually, the model represents a change
in process rather than a “frontal assault.”
The company contracts with thousands of
physicians and invites the participation of
all who meet USPM’s professional and
clinical standards. The goal is for the
CPMs to become dominant regional
providers of consumer- and employer-focused prevention, wellness, and healthy
aging services.
The three components of the CPM core
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structure are USPM, the hospital partner,
and the physician partners (Fig. 1). Ideally,
the CPM is located in a multispecialty
building that is near or appended to, but
not in, the hospital. Fifteen hundred square
feet is adequate space, and a CPM is designed to use staff, imaging, laboratory,
and cardiology services that are already in
place at the hospital.
CPM services are rendered by physicians
in a clinical environment where assessment
and prevention protocols are tailored to individual patients rather than populations.
The challenge is to create a one-stop/onesource for preventive care and the goal is
to establish 150 CPMs across the United
States over a five-year period that will
serve approximately 1000 patients per year
at each center. At full capacity, this represents approximately 0.1% of the US population. The CPM does not replace the patient’s relationship with his or her doctor.
Rather, it facilitates and enhances the opportunity for early detection, and encourages diligence among those with increased
risk factors.
The company envisions a geographical
distribution for CPMs that encompasses
both urban and rural areas. One hundred
fifty markets have been identified with population sizes as low as 150,000. Currently, a
CPM is operating in Sioux City, Iowa. In
terms of staffing, the hospital added only
one full-time employee, an RN administrator. Patient data is stored on a secure drive.
There is a private lounge and changing
rooms, television, and computers with Internet access. A concierge escorts the patient
from one diagnostic area to another. Flexibility in scheduling assures little downtime
between tests. Lifestyle coaching by an RN
is included for one year following diagnostic testing.
Preventive service packages are available
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THE CENTER FOR PREVENTIVE MEDICINE®
BUSINESS OVERVIEW

USPM National
Medical
Advisory
Board

U.S. PREVENTIVE
MEDICINETM

Provides:
Turnkey System
Management Services
Marketing (Local/National)
Billing/Collections
Point of Sale/Data/Web

Receives:
Management Fees
Share of Profits

Corporate Ownership
Management
Accredited Investors
Physicians

FIG. 1.

THE CENTER FOR
PREVENTIVE MEDICINE®
OWNERSHIP:

Accredited Investors
Physicians
Hospital
USPM

THE CENTER FOR
PREVENTIVE
MEDICINE®

Medical
Director
Local Medical
Advisory
Board

Physician Owners:
Service Fees
Share of Profits

Financial Overview
Global Payment By:
Consumers
Employers
Flex Spending/MSAs
Some Insurers

Contract Services
Provided By:
Physicians
Hospital
Diagnostic Imaging
Laboratory

Hospital Owners:
Service Fees
Share of Profits

Physician Network:
Specialist Fees
Personal
Physician
Consult Fees

U.S. Preventive Medicine, Inc. (USPM) center for preventive medicine (CPM) structure.

at different price points across the spectrum depending on the number and types
of screenings and/or tests performed. At
the high end, the cost per patient at a CPM
ranges from $1425 to $5950, with cardiology-specific packages ranging from $825 to
$3415. For those desiring lower-end preventive services, employers may purchase
packages for as little as $10 per employee
per year for basic risk stratification.
In practical terms, the US healthcare system is comprised of contracts and services.
The CPM model seeks to extend contracts
and services for preventive care beyond
their current bounds, leading to an appre-

ciable increase in wellness and continuity
of care.
National Advisory Board Reaction to the
USPM model
With a variety of stakeholders involved
in this enterprise, it is important to recognize different perspectives and address issues exclusive to each stakeholder. USPM
sought the expertise of the Department of
Health Policy at Jefferson Medical College
in convening a National Advisory Board to
serve as impartial consults to the company’s strategy team (Table 2). The goal
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U.S. PREVENTIVE
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TABLE 2
MEDICINE, INC. (USPM) ADVISORY BOARD

F. Kenneth Ackerman, Jr., F.A.C.H.E.,

F.A.C.M.P.E.
President
Clark Counsulting Healthcare Group
Minneapolis, Minnesota
David Auerbach, M.D., M.B.A.
Associate Professor, Internal Medicine–
General Medicine
University of Texas, Southwestern
Medical School
Dallas, Texas
Robert N. Butler, M.D.
President and Chief Executive Officer
International Longevity Center–USA
New York, New York
Anthony DiMarino, M.D.
Division Chief
Gastroenterology and Hepatology
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
James Fries, M.D.
Professor of Medicine (Emeritus)
Stanford University
Stanford, California
Robert Goldberg, Ph.D.
Director
Center for Medical Progress
Manhattan Institute
New York, New York
Lynn Helmer, M.D., F.A.C.P., M.B.A.,
F.A.C.P.E.
President
DRD Consulting, Inc.
Haddon Heights, New Jersey

Maulik Joshi, Dr.P.H.
Former President and Chief Executive
Officer
Delmarva Foundation for Medical
Care, Inc.
Easton, Maryland
Matias Klein
President and Chief Technology Officer
Ethidium Health Systems
Huntingdon Valley, Pennsylvania
Ronald Loeppke, M.D., M.P.H.
Chief Medical Officer and Executive
Vice President
CorSolutions, Inc.
Brentwood, Tennessee
S. Jay Olshansky, Ph.D.
Professor
School of Public Health
The Population Research Center at NORC
and
The University of Chicago
Chicago, Illinois
Jason Pride, C.E.A.
Vice President and Director of Research
The Haverford Trust Company
Radnor, Pennsylvania
Ann Scott Blouin, Ph.D., R.N.
Principal
Deloitte Consulting LLP
Chicago, Illinois
Richard Tewksbury
Manager Business Development
TRION Group
King of Prussia, Pennsylvania
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was to obtain objective feedback on the
company’s broad “ecosystem” approach to
transforming preventive health care, and to
elicit critique regarding the CPMs from clinical, financial, and business perspectives.
The National Advisory Board, comprised
of national-caliber healthcare industry leaders (up to 12 members representing medical
specialties, healthcare administration, and
employers), met in Philadelphia, Pennsylvania on March 17, 2006. At its initial meeting,
the board reviewed USPM concepts and the
existing business model, identified potential
risks and barriers, discussed the application
of evidence-based practices, and outlined an
outcomes research strategy. The board is expected to reconvene periodically to provide
guidance during the development of the
CPMs.
The chief questions posed were: Can this
model work? Does it make economic and
clinical sense? Board members agreed that
the USPM model represents a very innovative view of preventive medicine. They
noted that the concepts represent a departure from the conventional “public health”
approach to prevention, focusing instead on
privatization of the preventive health model.
One member observed, “The model is an interesting interface between high-tech and
high-touch.”
The USPM National Advisory Board
noted that the CPM product is highly individualized for the client/consumer but
must be rigorously standardized across
centers and regions (eg, a test for detecting
melanoma cannot be available at one center and not another). If the screening tool
(eg, a health status and risk assessment)
recommends a screening test or study to
consumers, it must be integrated into the
preventive options offered.
The opportunity exists to redefine US preventive medicine in terms of what it can be.
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The World Health Organization defines
health in broad terms, balancing physical,
emotional, social, and spiritual elements. The
Board suggested that a comprehensive definition of preventive medicine be built
around this model. Such a definition would
span the continuum from primary prevention to early intervention to tertiary prevention (ie, treating to prevent complications).
The Board encouraged the company to
continue to focus on helping individuals to
manage their own health and to negotiate the
healthcare process. Several members advised that the preventive medicine program
include such things as advance directives
and end-of-life care in addition to the risk assessments and screening tests. They questioned “What is done with a positive finding?” and, “Where will consumers be told to
‘start taking a baby aspirin’?” With this
model, these fall into the healthcare
provider’s domain. “We want an organization that is both accessible and economical—
one that avoids duplicating effort.” The company is working on standardizing the
information reported on each test performed, and the company’s Web site will
provide additional detail for physicians and
for individuals who have concerns.
Employer-related issues. The chief issue for
employers is the differential in the value
propositions. “Productivity is the new currency for employers looking to ‘buy health’
for their workforces.” Employers are seeking products that cover all health care for
all of their employees—both prevention
and treatment. The concierge-style CPMs
are impressive, but they are designed and
priced for executives. Board members encouraged the company to focus similar
attention on continued development of
products and services employers might
purchase for their general workforces.
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Physician-related issues. Several Board
members noted potential challenges at the
provider level in the model. “What are the
implications if a patient is diagnosed with
a genetic disorder or predisposition?” The
Board also commented on the potential for
resistance from physicians when subclinical or presumptive diagnostics are introduced. “Physicians resist having their patients get tests outside of the doctor-patient
context.”
The Board discussed the importance of educating physicians regarding the significance of specific tests and counseling scores.
The key message was that maintaining good
relationships with physicians will be critical
to the success of the model. “Always ask the
name of the person’s doctor and report to
that doctor before the patient does.”

S-13

ing in personal prevention and early detection. Also, plans are under way to provide affordable screening programs via a
Web-based health status and risk assessment tool, and education via “The Prevention Channel.”
Partnering. The Board advised USPM to
choose its hospital and physician partners
very carefully to ensure the best clinical
quality in a given region. “Selection of partners will set the tone relative to perceived
quality.”

Business model. The model assumes unused capacity at hospitals. For example, the
hospital with the fully operational CPM has
an entire wing dedicated to prevention and
fitness. Board members commented that
many hospitals in the United States and
Ethical issues. As they are presently Canada have no excess capacity.
conceived, CPMs are accessible to and afMedical content and standards
fordable by “high-end” consumers (ie, emThe Board emphasized the importance of
ployer-sponsored executives and consumers willing and able to pay $1500 out establishing and maintaining standards of
of pocket). Although other components are care and evaluating quality across CPMs.
more universally accessible (eg, The Pre- They raised questions about the practice of
vention Channel), the Board cautioned that individual medicine as contrasted with
the CPMs may give the appearance of elit- population medicine. Even though most
ism or “cherry picking.” They encouraged people are risk averse there are exceptions,
the company to focus some of its innova- and the permissible degree of variation
tive capital on a solution to address pre- from the standard must be established (eg,
vention for the huge uninsured US popu- a consumer who desires a liver biopsy
lation, as well as those insured by Medicare every three months when the risk of dying
and Medicaid. Additional opportunities in- from the test is greater than the risk of dyclude fashioning programs for specific em- ing from the disease).
The Board stressed the value of involvployers (eg, police, firefighters) and programs that consider regional culture, ing clinical partners in clinical content demaking certain that customer service train- terminations and package designs. There
should be a valid reason for doing each
ing extends to the physician.
While sensitive to this critique, USPM re- test—one that is understood by the conported that experience at its prototype sumer and the physician. Additional deCPM in Sioux City, Iowa suggests that ed- mands on physician time may be alleviated
ucated consumers are interested in invest- in part by developing decision trees.
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Additional “prevention package” offer- • If the expected outcome is extended
ings suggested by the Board were a cardi“healthy life,” gauge and monitor this.
ology service package, and a women’s pre- • Does participation reduce the risk of
ventive health package (ie, reproductive
death?
health,
cardiovascular,
osteoporosis • Does participation increase the quality of
screening).
life?
• Does living a healthier life lead to greater
Evidence-based medicine. The healthcare inaccumulation of wealth?
dustry is seeking evidence-based medicine. • Does living a healthier life result in fewer
Purchasers, providers, and consumers exsick days and more productivity at work?
pect it. Wherever possible, there should be • What is an acceptable outcome? Does
evidence to support the program. Increasearly detection always result in a better
ingly, the onus of responsibility for an indioutcome?
vidual’s health is on the consumer. Because
Preventive care is a long-term commitof this, it is important to educate and help
ment. One would expect differences in costs
manage the expectations of consumers.
The Board noted that the model deals as for a person aged 50 versus a person aged 60.
much with “early discovery” as with pre- A study comparing out-of-pocket and other
vention. In deciding whether to be totally costs for participants versus nonparticipants
evidence based (ie, adhere to relatively con- at various ages would be of great interest.
An information technology system is an
servative USPSTF recommendations) or to
follow suggestions from the most current integral part of a research solution. Health
literature (ie, practice cutting-edge preven- status assessments, procedures, and test retion and early detection), the Board advised sults form a core data set and an umbrella
taking a proactive approach. “Framingham questionnaire could be administered annucannot predict for individuals. It is only ally to all program participants with evaluation embedded into the system. Another
useful for populations.”
element to consider is a PHR on the Web
Outcomes measures and studies. Outcomes site that would enable integration of the inmeasurements are essential for demonstrat- dividual participant’s prevention experiing the positive effects of the model—for ex- ence and test results.
ample, a reduction in morbidity or mortality
By the meeting’s end, the key points were
that results in increased productivity. The synthesized in the form of a proposed misBoard strongly recommended that USPM sion statement:
create a research arm to track participants in
programs and analyze data for changes in 1. Improve American health.
behavior and health risks. They noted rich 2. Improve individual health via lifestyle
sources of data including existing data from
changes.
CPMs, online health status surveys, and risk 3. Detect disease at an early stage.
assessments. In addition to studies, the 4. Evaluate outcomes of prevention efforts
Board stressed the importance of conducting
thoroughly.
scholarly reviews of the literature.
5. Conduct scholarly reviews of the literaObservational studies might be designed
ture.
to evaluate the effect of USPM’s programs 6. Ensure adequate financial return for
and answer important questions such as:
preventive services.

CONCLUSION
The US healthcare system’s failure to
meet targets for prevention and early detection of chronic conditions has raised
concerns throughout the industry. Although improvements have resulted from
the efforts of health plans, disease management companies, and public sector
agencies, preventive health care continues
to fall short of expectations for a variety
of reasons including system issues (eg, rationing or restricting coverage for preventive services by insurers) and consumer
behavior issues (eg, failure to adhere to
key healthy lifestyle characteristics). In
this supplement, we have described one
innovative strategy for improving the
amount and quality of prevention, early
detection, and healthy lifestyle education—the creation of a national network of
CPMs delivering consistent, reliable preventive services and solutions to consumers across the country. We also present a national expert panel’s reaction to

the strategy. The USPM model is of particular interest because of its broad, encompassing scope—the “ecosystem” concept—and its novel approaches to
physician and hospital partnering, diagnostic/screening test packaging and delivery, and consumer engagement and education regarding preventive health.
In the months since the National Advisory Board met to evaluate and critique its
model, USPM executives have worked to
address the board’s recommendations (eg,
seeking, as partners, institutions with a
“passion for prevention,” taking steps toward building a research arm).
Although we have highlighted one approach in this supplement, there are other
possible routes to improving preventive
health nationwide. The overarching message is that refocusing on prevention and
early detection may be the first stage in a
“cure” for the healthcare crisis in the
United States.
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